RFP
AURA icon

Root Financial Partners’s Aura Biosciences AURA Stock Holding History

Root Financial Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47 Hold
7
– – ﹤0.01% 3385
2025
Q4 		$38 Buy
+7
New +$42 ﹤0.01% 2395

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Root Financial Partners's AURA Position: Q1 2026 in Review

Root Financial Partners held its Aura Biosciences (AURA) position steady in Q1 2026 at 7 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #3385.

Root Financial Partners first reported a position in AURA in Q4 2025 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Root Financial Partners held 7 shares of Aura Biosciences worth $47 as of Q1 2026.
  • Root Financial Partners left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3385 holding.
  • Root Financial Partners first reported a position in Aura Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.